MedTrace Logo

Thermocoagulation for Treatment of Precancerous Cervical Lesions

NCT04191967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 379

Last updated 2023-01-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety, acceptability, and efficacy of Thermocoagulation for treatment of precancerous lesions among HIV-positive women in a screen-and-treat program in Western Kenya.

Conditions

Interventions

DEVICE

Thermocoagulation

Treatment of positive screening results will be performed using the Liger Thermocoagulator device

Sponsors & Collaborators

Principal Investigators

  • Chemtai Mungo, MD, MPH · University of California, San Francisco

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-25
Primary Completion
2021-11-30
Completion
2021-11-30
FDA Device
Yes

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191967 on ClinicalTrials.gov